# Secondary Prevention of Clostridioides Difficile Using Vancomycin

> **NCT06979609** · PHASE2,PHASE3 · RECRUITING · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 300 (estimated)

## Conditions studied

- Clostridioides Difficile Infection
- Clostridioides Difficile Infection Recurrence
- Clostridoides Difficile Associated Disease

## Interventions

- **DRUG:** Oral Vancomycin Prophylaxis
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06979609
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2028-10-01
- **Final completion:** 2029-10-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06979609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06979609, "Secondary Prevention of Clostridioides Difficile Using Vancomycin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06979609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*